Owen B. Wallace - Net Worth and Insider Trading
Owen B. Wallace Net Worth
The estimated net worth of Owen B. Wallace is at least $439,089 dollars as of 2024-09-20. Owen B. Wallace is the Chief Scientific Officer of Fulcrum Therapeutics Inc and owns about 127,088 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $439,089. Details can be seen in Owen B. Wallace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Owen B. Wallace has not made any transactions after 2020-07-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Owen B. Wallace
Owen B. Wallace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Owen B. Wallace owns 2 companies in total, including Fulcrum Therapeutics Inc (FULC) , and Monte Rosa Therapeutics Inc (GLUE) .
Click here to see the complete history of Owen B. Wallace’s form 4 insider trades.
Insider Ownership Summary of Owen B. Wallace
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2020-07-08 | Chief Scientific Officer |
| GLUE | Monte Rosa Therapeutics Inc | 2021-06-23 | Chief Scientific Officer |
Owen B. Wallace Latest Holdings Summary
Owen B. Wallace currently owns a total of 1 stock. Owen B. Wallace owns 127,088 shares of Fulcrum Therapeutics Inc (FULC) as of July 8, 2020, with a value of $439,089.
Latest Holdings of Owen B. Wallace
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2020-07-08 | 127,088 | 3.46 | 439,089 |
Holding Weightings of Owen B. Wallace
Owen B. Wallace Form 4 Trading Tracker
According to the SEC Form 4 filings, Owen B. Wallace has made a total of 6 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 2,951 shares on July 8, 2020, which brought Owen B. Wallace around $59,020.
Insider Trading History of Owen B. Wallace
- 1
Owen B. Wallace Trading Performance
Owen B. Wallace Ownership Network
Owen B. Wallace Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Owen B. Wallace is the Chief Scientific Officer of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Owen B. Wallace made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,330 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,030 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Owen B. Wallace Mailing Address
Above is the net worth, insider trading, and ownership report for Owen B. Wallace. You might contact Owen B. Wallace via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
